P J Carder

Relationship Between Quantitative Estrogen and Progesterone Receptor Expression and Human Epidermal Growth Factor Receptor 2 (HER-2) Status With Recurrence in the Arimidex, Tamoxifen, Alone or in Combination Trial

Mitch Dowsett, Craig Allred, Jill Knox et al. · Journal of Clinical Oncology · 2008 · 465 citations

Medicine, Endocrinology, Oncology +17

Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen.

Jacqui Adams, P J Carder, Sarah Downey et al. · PubMed · 2000 · 342 citations

Medicine, Oncology, Pathology +12

Updated UK Recommendations for HER2 assessment in breast cancer

Emad A. Rakha, Sarah E. Pinder, John M.S. Bartlett et al. · Journal of Clinical Pathology · 2014 · 259 citations · Full text

Medicine, Molecular Medicine, Oncology +13

Reduced expression of oestrogen receptor β in invasive breast cancer and its re‐expression using DNA methyl transferase inhibitors in a cell line model

G. Skliris, Kailas Munot, Sandra Bell et al. · The Journal of Pathology · 2003 · 201 citations

Medicine, Molecular Biology, Oncology +15

Distinct expression patterns of ER  and ER  in normal human mammary gland

Valerie Speirs, G. Skliris, S. E. Burdall et al. · Journal of Clinical Pathology · 2002 · 148 citations · Full text

Medicine, Endocrinology, Pathology +15